463 related articles for article (PubMed ID: 8953976)
1. Macular scatter ('grid') laser treatment of poorly demarcated subfoveal choroidal neovascularization in age-related macular degeneration. Results of a randomized pilot trial.
Bressler NM; Maguire MG; Murphy PL; Alexander J; Margherio R; Schachat AP; Fine SL; Stevens TS; Bressler SB
Arch Ophthalmol; 1996 Dec; 114(12):1456-64. PubMed ID: 8953976
[TBL] [Abstract][Full Text] [Related]
2. Indirect scatter laser photocoagulation to subfoveal choroidal neovascularization in age-related macular degeneration.
Arnold J; Algan M; Soubrane G; Coscas G; Barreau E
Graefes Arch Clin Exp Ophthalmol; 1997 Apr; 235(4):208-16. PubMed ID: 9143888
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of argon green vs krypton red laser for photocoagulation of subfoveal choroidal neovascularization in the macular photocoagulation study. Macular Photocoagulation Study (MPS) Group.
Arch Ophthalmol; 1994 Sep; 112(9):1176-84. PubMed ID: 7522004
[TBL] [Abstract][Full Text] [Related]
4. Laser photocoagulation of subfoveal neovascular lesions of age-related macular degeneration. Updated findings from two clinical trials. Macular Photocoagulation Study Group.
Arch Ophthalmol; 1993 Sep; 111(9):1200-9. PubMed ID: 7689827
[TBL] [Abstract][Full Text] [Related]
5. Occult choroidal neovascularization. Influence on visual outcome in patients with age-related macular degeneration. Macular Photocoagulation Study Group.
Arch Ophthalmol; 1996 Apr; 114(4):400-12. PubMed ID: 8602776
[TBL] [Abstract][Full Text] [Related]
6. Persistent and recurrent neovascularization after laser photocoagulation for subfoveal choroidal neovascularization of age-related macular degeneration. Macular Photocoagulation Study Group.
Arch Ophthalmol; 1994 Apr; 112(4):489-99. PubMed ID: 7512335
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic benefits of infrared (810-nm) diode laser macular grid photocoagulation in prophylactic treatment of nonexudative age-related macular degeneration: two-year results of a randomized pilot study.
Olk RJ; Friberg TR; Stickney KL; Akduman L; Wong KL; Chen MC; Levy MH; Garcia CA; Morse LS
Ophthalmology; 1999 Nov; 106(11):2082-90. PubMed ID: 10571341
[TBL] [Abstract][Full Text] [Related]
8. Scatter macular photocoagulation for subfoveal neovascular membranes in age-related macular degeneration. A pilot study.
Tornambe PE; Poliner LS; Hovey LJ; Taren D
Retina; 1992; 12(4):305-14. PubMed ID: 1283021
[TBL] [Abstract][Full Text] [Related]
9. Laser photocoagulation of subfoveal recurrent neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group.
Arch Ophthalmol; 1991 Sep; 109(9):1232-41. PubMed ID: 1718251
[TBL] [Abstract][Full Text] [Related]
10. Laser treatment in eyes with large drusen. Short-term effects seen in a pilot randomized clinical trial. Choroidal Neovascularization Prevention Trial Research Group.
Ophthalmology; 1998 Jan; 105(1):11-23. PubMed ID: 9442774
[TBL] [Abstract][Full Text] [Related]
11. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.
Arch Ophthalmol; 1999 Oct; 117(10):1329-45. PubMed ID: 10532441
[TBL] [Abstract][Full Text] [Related]
12. Grid laser treatment of occult choroidal neovascularization in age related macular degeneration.
Cardillo Piccolino F; Ghiglione D; Allegri P
Int Ophthalmol; 1993 Apr; 17(2):77-83. PubMed ID: 7691775
[TBL] [Abstract][Full Text] [Related]
13. Visual outcome after laser photocoagulation for subfoveal choroidal neovascularization secondary to age-related macular degeneration. The influence of initial lesion size and initial visual acuity. Macular Photocoagulation Study Group.
Arch Ophthalmol; 1994 Apr; 112(4):480-8. PubMed ID: 7512334
[TBL] [Abstract][Full Text] [Related]
14. Occult choroidal neovascularization in age-related macular degeneration. A natural history study.
Stevens TS; Bressler NM; Maguire MG; Bressler SB; Fine SL; Alexander J; Phillips DA; Margherio RR; Murphy PL; Schachat AP
Arch Ophthalmol; 1997 Mar; 115(3):345-50. PubMed ID: 9076206
[TBL] [Abstract][Full Text] [Related]
15. Submacular surgery trials randomized pilot trial of laser photocoagulation versus surgery for recurrent choroidal neovascularization secondary to age-related macular degeneration: I. Ophthalmic outcomes submacular surgery trials pilot study report number 1.
Bressler NM; Bressler SB; Hawkins BS; Marsh MJ; Sternberg P; Thomas MA;
Am J Ophthalmol; 2000 Oct; 130(4):387-407. PubMed ID: 11024412
[TBL] [Abstract][Full Text] [Related]
16. Five-year follow-up of fellow eyes of individuals with ocular histoplasmosis and unilateral extrafoveal or juxtafoveal choroidal neovascularization. Macular Photocoagulation Study Group.
Arch Ophthalmol; 1996 Jun; 114(6):677-88. PubMed ID: 8639078
[TBL] [Abstract][Full Text] [Related]
17. Radiation therapy for subfoveal choroidal neovascular membranes in age-related macular degeneration. A pilot study.
Bergink GJ; Deutman AF; van den Broek JF; van Daal WA; van der Maazen RW
Graefes Arch Clin Exp Ophthalmol; 1994 Oct; 232(10):591-8. PubMed ID: 7528158
[TBL] [Abstract][Full Text] [Related]
18. The influence of treatment extent on the visual acuity of eyes treated with Krypton laser for juxtafoveal choroidal neovascularization. Macular Photocoagulation Study Group.
Arch Ophthalmol; 1995 Feb; 113(2):190-4. PubMed ID: 7532395
[TBL] [Abstract][Full Text] [Related]
19. Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes-TAP report No. 3.
Bressler NM; Arnold J; Benchaboune M; Blumenkranz MS; Fish GE; Gragoudas ES; Lewis H; Schmidt-Erfurth U; Slakter JS; Bressler SB; Manos K; Hao Y; Hayes L; Koester J; Reaves A; Strong HA;
Arch Ophthalmol; 2002 Nov; 120(11):1443-54. PubMed ID: 12427056
[TBL] [Abstract][Full Text] [Related]
20. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynamic therapy report 2.
Verteporfin In Photodynamic Therapy Study Group
Am J Ophthalmol; 2001 May; 131(5):541-60. PubMed ID: 11336929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
